Leaflet GRANISETRON ACTAVIS 2mg film-coated tablets


Indicated for: chemotherapy-induced nausea and vomiting

Route of administration: oral

Substance: granisetron (antiemetic)

ATC: A04AA02 (Alimentary tract and metabolism | Antiemetics and antinauseants | Serotonin (5ht3) antagonists)

Granisetron is a medication used to prevent and treat nausea and vomiting caused by chemotherapy, radiation therapy, or surgery. It belongs to a class of drugs known as 5-HT3 receptor antagonists.

This medication works by blocking the action of serotonin, a natural substance in the body that can trigger nausea and vomiting. It is available in tablet form, transdermal patches, or injectable solutions.

Granisetron is generally well-tolerated but may cause side effects such as headaches, constipation, or dizziness. In rare cases, severe allergic reactions may occur.

It is important to use granisetron as directed by your doctor and to inform medical staff about any other medications you are taking to avoid interactions.

General data about GRANISETRON ACTAVIS 2mg

  • Substance: granisetron
  • Date of last drug list: 01-05-2026
  • Commercial code: W54348002
  • Concentration: 2mg
  • Pharmaceutical form: film-coated tablets
  • Quantity: 10
  • Product type: generic
  • Price: 350.10 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ACTAVIS HF. - ISLANDA
  • Holder: ACTAVIS GROUP PTC EHF. - ISLANDA
  • Number: 6700/2014/02
  • Shelf life: 3 years

Concentrations available for granisetron

  • 1mg
  • 1mg/1ml
  • 1mg/ml
  • 20mcg/ml
  • 2mg
  • 3.1mg/24h
  • 3mg/3ml